MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9

被引:0
|
作者
Zhao, Fuyou [1 ]
Lv, Jie [4 ]
Gan, Huaiyong [2 ]
Li, Yumei [1 ]
Wang, Ri [1 ]
Zhang, Haoran [1 ]
Wu, Qiong [1 ]
Chen, Yuqing [3 ]
机构
[1] Bengbu Med Coll, Affiliated Hosp 1, Dept Med Oncol, Bengbu 233000, Anhui, Peoples R China
[2] Bengbu Med Coll, Affiliated Hosp 1, Dept Pathol, Bengbu 233000, Anhui, Peoples R China
[3] Bengbu Med Coll, Affiliated Hosp 1, Dept Resp Dis, Bengbu 233000, Anhui, Peoples R China
[4] Bengbu Med Coll, Dept Microbiol, Bengbu 233000, Anhui, Peoples R China
关键词
miR-1247; miRNA profile; osteosarcoma; MAP3K9; STEM-CELLS; DIFFERENTIATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
microRNAs (miRNA) are regulators of gene expression, but little is known about miRNA expression profiles in stem cells of osteosarcoma (OS). C117 and Stro-1 are known stem cell markers of OS. In the study, CD117 and stro-1 positive (CD117(+)stro-1(+)) and CD117 and stro-1 negative (CD117 stro-1) cells were isolated from MG63 cells CD117(+)stro-1(+) cells showed more metastatic ability and stem cell formation rate than CD117 stro-1 ones. To find the difference between CD117(+) stro-1(+) and CD117 stro-1 cells, the miRNA expression profile was examined using DNA microarray. MicroRNAs were differentially expressed in osteosarcoma cells with CD117(+) stro-1(+) and CD117(-) stro-1. The significant miRNAs included miR-15a, miR-302a, miR-423-5p, miR-1247, miR-1243 and others, which were confirmed by real time RT-PCR. The significant down-regulated miR-1247 was confirmed that was a potential tumor suppressor by targeting MAP3K9. Our results indicated that dysregulation of miRNAs is involved in osteosarcoma and miR-1247 plays an important role in progression of osteosarcoma.
引用
收藏
页码:1451 / 1458
页数:8
相关论文
共 1 条
  • [1] LncRNA SLC16A1-AS1 participates in the initiation and progression of colorectal cancer by regulating MAP3K9 expression through targeting miR-515-5p
    Xu, Wanxing
    Bi, Suzhen
    Xing, Meichun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (11): : 5539 - 5550